Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto. Pham C, Niu F, Hui RL, Le KN, et al. Clin Rheumatol 2024;43:1269-1270.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pham C, Niu F, Hui RL, Le KN, et al. Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto. Clin Rheumatol 2024;43:1269-1270.
PMID: 37989973